Fifth Third Bancorp trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 6.0% during the 3rd quarter, Holdings Channel.com reports. The fund owned 65,718 shares of the exchange traded fund’s stock after selling 4,226 shares during the quarter. Fifth Third Bancorp’s holdings in SPDR S&P Biotech ETF were worth $6,585,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Capital A Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $26,000. Johnson Financial Group Inc. purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at about $31,000. Twin Peaks Wealth Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at about $32,000. Davis Capital Management bought a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at about $35,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth about $40,000.
SPDR S&P Biotech ETF Price Performance
Shares of NYSEARCA:XBI opened at $124.63 on Wednesday. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $132.09. The company has a market cap of $8.33 billion, a PE ratio of 11.47 and a beta of 0.93. The stock’s 50-day moving average is $124.47 and its 200 day moving average is $110.60.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Energy Security Is Now National Security – Positioning Is Happening Now
- When to buy gold (mathematically)
- The gold chart Wall Street is terrified of…
- The “Bomb” in America’s Basement
- Unlocked: Elon Musk’s Next Big IPO
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
